Life Sciences
Europe Guide 2024 : Germany
Band 3
Contact number
+49 69 27 30 80About
Provided by Freshfields
Please visit the Freshfields website for more details about our work in this category: http://www.freshfields.com/en-gb/what-we-do/industries/pharmaceuticals-medical-products-and-healthcare/
Chambers Review
Freshfields Bruckhaus Deringer has a strong focus on cross-border transactions in the pharmaceutical and biotechnology sectors. In addition to product portfolio deals it assists with the drafting of collaboration, research and development agreements. The department also handles the regulatory aspects of transactions and is active on data protection, market access and medical device issues. It offers further strength in patent-related mandates, including enforcement and ownership cases, as well as product liability litigation.
Philipp Dohnke and Michael Ramb are key contacts for the practice.
Work Highlights
- Freshfields advised Grünenthal on a joint venture collaboration with Japanese speciality pharmaceutical company Kyowa Kirin relating to its established medicines portfolio.
Strengths
Provided by Chambers
"The team always acts promptly and is perfectly coordinated. It always provides valuable advice."
"The firms relationship management is great."
"I think the German team is very impressive; the lawyers know their stuff and they have smart associates. They work seamlessly and are very coordinated across offices. The team delivers and you know you get the right product."
"The team has a very good understanding of our business operations and has therefore become a very good adviser in terms of commercial matters."
"The team always acts promptly and is perfectly coordinated. It always provides valuable advice."
"The firms relationship management is great."
"I think the German team is very impressive; the lawyers know their stuff and they have smart associates. They work seamlessly and are very coordinated across offices. The team delivers and you know you get the right product."
"The team has a very good understanding of our business operations and has therefore become a very good adviser in terms of commercial matters."